(Q34749204)

4 August 2017

1 reference

title

Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options (English)

1 reference

4 August 2017

0 references

0 references

0 references

0 references

Herbert Y Meltzer

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Current Psychiatry Reports

4 August 2017

published in

1 reference

4 August 2017

volume

4

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

279-283

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-996-0047-6

4 August 2017

exact match

0 references

cites work

Schizophrenia: a life-shortening disease.

1 reference

https://api.crossref.org/works/10.1007%2FS11920-996-0047-6

Suicide: the public health crisis of our time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-996-0047-6

Mortality in schizophrenia--the Iowa Record-Linkage Study: a comparison with general population mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-996-0047-6

Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-996-0047-6

Suicide attempts associated with akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-996-0047-6

Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-996-0047-6

Impact of clozapine on completed suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-996-0047-6

Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine.

21 January 2018

1 reference

12 December 2020

Suicide and schizophrenia

1 reference

12 December 2020

Observations on suicide in chronic schizophrenics

1 reference

12 December 2020

Suicide and schizophrenia: data from a prospective community treatment study

1 reference

12 December 2020

Factors predicting suicide in psychotic patients.

1 reference

12 December 2020

The Iowa 500: suicide in mania , depression, and schizophrenia

1 reference

12 December 2020

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

12 December 2020

Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment

1 reference

12 December 2020

Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database

1 reference

12 December 2020

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

1 reference

12 December 2020

Mortality in current and former users of clozapine.

1 reference

12 December 2020

The occurrence and characteristics of suicidal preoccupation and acts in schizophrenia

1 reference

12 December 2020

Depression, hopelessness and suicide in chronic schizophrenia

1 reference

12 December 2020

Schizophrenia--a high-risk factor for suicide: clues to risk reduction

1 reference

12 December 2020

Evaluation of suicide prevention after attempted suicide

1 reference

12 December 2020

Mortality and causes of death in first admitted schizophrenic patients

1 reference

12 December 2020

Suicide associated with akathisia and depot fluphenazine treatment

1 reference

12 December 2020

Late suicide in former mental patients

1 reference

12 December 2020

10.1007/S11920-996-0047-6

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1044370613

0 references

1 reference